Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21 R110 .
Paul J HengeveldY Emre ErtemJulie M N DuboisClemens H M MellinkAnne-Marie van der Kevie-KersemaekersLudo M EversKim HeezenP Martijn KolijnOlaf R F MookM Mahdi MotazackerKazem NasserinejadS KerstingPeter E WesterweelCarsten Utoft NiemannArnon P KaterAnton W LangerakMark-David LevinPublished in: Leukemia (2022)